
Risk Analysis for Merck and Company: Pro...
Bodily, Samuel E.;...
Risk Analysis for Merck and Company: Product KL-798
Bodily, Samuel E.; Faulk, John
QA-0600 | Published September 25, 2003 | 8 pages. Case
Collection: Darden School of Business
Product Details
This case builds on the case "Merck & Company: Product KL-798" (UVA-QA-0582) by providing market uncertainties for the drug (drug quality, the presence of a competitor, market growth, and the time to the drug's release). Student and faculty spreadsheets are provided for the calculation of net present values for the scenarios. There is an additional challenge of how to treat the several downstream decisions (using OptQuest, for example) and how to value the license opportunity. A teaching note is also available to registered faculty members.
0
Products To Upsell

Global Medical Imaging, LLC
Hess, Edward D.; G...

Enchanting Travels
Hess, Edward D.; M...

Better World Books
Hess, Edward D.; G...

Valuation of "Plain-Vanilla" Interest-Ra...
Conroy, Robert M.;...

FindingFIT
Clawson, James G.

List Testing Exercise: Economic Selectio...
Pfeifer, Phillip E...

An Introduction to Case Teaching (Part 1...
Clawson, James G.

What Is Giving Voice to Values? (VIDEO)
Gentile, Mary

Giving Voice to Values: An Educators' Pr...
DARDEN, Darden

Digital Marketing Simulation: Media Attr...
Venkatesan, Rajkum...

Dr. Bronner's: Do Psychedelics Fit with ...
Freeman, R. Edward...

AMP - Strategic Innovation & Entrepreneu...
Gupta, Uday

Accounting for Owners’ Equity
Lynch, Luann J.; B...

Test Syllabus 45
Daren Business Sch...

Athlete Brands: How to Benefit from Your...
Whitler, Kimberly ...

What is Design Thinking? (VIDEO)
Liedtka, Jeanne M.

Copyright Permissions
Daren Business Sch...

Thinking Strategically About Communicati...
West, June A.

Optix Corporation
Powell, Elizabeth ...

Leaders Bank: Creating a Great Place to ...
Hess, Edward D.; G...

LG Investments, LLC: A Family Business i...
Hess, Edward D.

Finance People
Schill, Michael J.